RT Journal Article
SR Electronic
T1 Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000798
DO 10.1136/jitc-2020-000798
VO 8
IS 1
A1 Xie, Lu
A1 Xu, Jie
A1 Sun, Xin
A1 Guo, Wei
A1 Gu, Jin
A1 Liu, Kuisheng
A1 Zheng, Bingxin
A1 Ren, Tingting
A1 Huang, Yi
A1 Tang, Xiaodong
A1 Yan, Taiqiang
A1 Yang, Rongli
A1 Sun, Kunkun
A1 Shen, Danhua
A1 Li, Yuan
YR 2020
UL http://jitc.bmj.com/content/8/1/e000798.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.